IO Biotech Earnings Estimate

By analyzing IO Biotech's earnings estimates, investors can diagnose different trends across IO Biotech's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for IO Biotech is based on EPS before non-recurring items and includes expenses related to employee stock options. IO Biotech is projected to generate -0.335 in earnings per share on the 31st of December 2024. IO Biotech earnings estimates module stress-tests analyst consensus about projected IO Biotech EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as IO Biotech, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing IO Biotech's earnings estimates, investors can diagnose different trends across IO Biotech's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to about (793.8 K) in 2024Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IO Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.